Paper33339441
Various Aspects of a Gene Editing System-CRISPR-Cas9.
Janik E and 5 others. Int J Mol Sci, 2020. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. Various Aspects of a Gene Editing System-CRISPR-Cas9. Papers, record 33339441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33339441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Cas Systems | Major topic |
| Gene Editing | Major topic |
| Animals | |
| Epigenesis, Genetic | |
| Genetic Therapy | |
| Humans |
Source PubMed
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28689169 | Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions. | Br J Ophthalmol | 2017 | https://conductscience.org/library/papers/28689169 | PubMed |
| 2 | 28614576 | The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review. | JAMA Cardiol | 2017 | https://conductscience.org/library/papers/28614576 | PubMed |
| 3 | 31857715 | Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/31857715 | PubMed |
| 4 | 25894090 | CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. | Protein Cell | 2015 | https://conductscience.org/library/papers/25894090 | PubMed |
| 5 | 28215090 | Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance. | Bioconjug Chem | 2017 | https://conductscience.org/library/papers/28215090 | PubMed |
| 6 | 29382940 | The future of CRISPR technologies in agriculture. | Nat Rev Mol Cell Biol | 2018 | https://conductscience.org/library/papers/29382940 | PubMed |
| 7 | 30013045 | An enhanced CRISPR repressor for targeted mammalian gene regulation. | Nat Methods | 2018 | https://conductscience.org/library/papers/30013045 | PubMed |
| 8 | 22223736 | The crystal structure of TAL effector PthXo1 bound to its DNA target. | Science | 2012 | https://conductscience.org/library/papers/22223736 | PubMed |
| 9 | 22558257 | CRISPR interference directs strand specific spacer acquisition. | PLoS One | 2012 | https://conductscience.org/library/papers/22558257 | PubMed |
| 10 | 30664785 | Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. | Nat Med | 2019 | https://conductscience.org/library/papers/30664785 | PubMed |
| 11 | 23360964 | Efficient genome editing in zebrafish using a CRISPR-Cas system. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360964 | PubMed |
| 12 | 29358495 | History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology. | J Bacteriol | 2018 | https://conductscience.org/library/papers/29358495 | PubMed |
| 13 | 30348755 | Staphylococcus aureus Cas9 is a multiple-turnover enzyme. | RNA | 2019 | https://conductscience.org/library/papers/30348755 | PubMed |
| 14 | 11952905 | Identification of genes that are associated with DNA repeats in prokaryotes. | Mol Microbiol | 2002 | https://conductscience.org/library/papers/11952905 | PubMed |
| 15 | 26990991 | Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9. | Mol Cell | 2016 | https://conductscience.org/library/papers/26990991 | PubMed |
| 16 | 25743786 | CRISPR/Cas9: a molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae. | FEMS Yeast Res | 2015 | https://conductscience.org/library/papers/25743786 | PubMed |
| 17 | 28624224 | Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28624224 | PubMed |
| 18 | 26765770 | Current Progress in Therapeutic Gene Editing for Monogenic Diseases. | Mol Ther | 2016 | https://conductscience.org/library/papers/26765770 | PubMed |
| 19 | 23939622 | CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. | Nucleic Acids Res | 2013 | https://conductscience.org/library/papers/23939622 | PubMed |
| 20 | 27096365 | Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. | Nature | 2016 | https://conductscience.org/library/papers/27096365 | PubMed |
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698535 | Impact of oxidative stress on malignant tumor progression and emerging therapeutic strategies. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42698535 | PubMed |
| 42646121 | Establishment of CRISPR/Cas9 Genome Editing in Ganoderma boninense and Functional Validation of Hydrophobin-2 as a Virulence Determinant. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42646121 | PubMed |
| 42610144 | AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42610144 | PubMed |
| 42501080 | Bacterial immune systems. | Antonie Van Leeuwenhoek | 2026 | https://conductscience.org/library/papers/42501080 | PubMed |
| 42353311 | Regular Aerobic Exercise Can Effectively Ameliorate the Skeletal Muscle and Mitochondrial Function Impairments Caused by bves Deficiency in Zebrafish. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353311 | PubMed |
| 42277925 | Advances in molecular breeding of medicinal plants. | Mol Hortic | 2026 | https://conductscience.org/library/papers/42277925 | PubMed |
| 42272755 | Multilayer regulation of CRISPR systems: integrating anti-CRISPR proteins, CRISPRi/a, and quorum sensing networks. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42272755 | PubMed |
| 42199538 | CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42199538 | PubMed |
| 42182524 | Prospects and challenges in using engineered lactic acid bacteria in aquaculture applications. | Eng Microbiol | 2026 | https://conductscience.org/library/papers/42182524 | PubMed |
| 42112429 | Targeting biofilm-driven antibiotic resistance: emerging mechanisms and next-generation therapeutic interventions. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42112429 | PubMed |
| 41741059 | Emerging Considerations in Transfusion Medicine: Hematopoietic Stem and Progenitor Cell Collection for Gene Therapy for Sickle Cell Disease and Transfusion-Dependent Thalassemia. | Clin Lab Med | 2026 | https://conductscience.org/library/papers/41741059 | PubMed |
| 41635917 | Navigating the next frontier in biomedicine: breakthroughs and insights in nucleic acid therapeutics. | Chem Sci | 2026 | https://conductscience.org/library/papers/41635917 | PubMed |
| 41599334 | Establishment of CRISPR-Cas9-Mediated Gene Editing in the Swimming Crab Portunus trituberculatus. | Molecules | 2026 | https://conductscience.org/library/papers/41599334 | PubMed |
| 41323732 | Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41323732 | PubMed |
| 41203870 | Coloring target and off-target effects of genetically modified nucleases by blue & white colony assays. | Biotechnol Lett | 2025 | https://conductscience.org/library/papers/41203870 | PubMed |
| 41189702 | Immune Landscape in Kidney Transplantation. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41189702 | PubMed |
| 41188895 | Knowledge mapping and bibliometric insights into gene therapy for rare inherited hematologic pathologies: focus on sickle cell disease, hemophilia, and thalassemia. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/41188895 | PubMed |
| 41156802 | Key Technologies of Synthetic Biology in Industrial Microbiology. | Microorganisms | 2025 | https://conductscience.org/library/papers/41156802 | PubMed |
| 41091245 | CRISPR-Cas opens a new era of antimicrobial therapy as a powerful gene editing tool. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/41091245 | PubMed |
| 40901270 | Therapeutic Opportunities of Marfan Syndrome: Current Perspectives. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40901270 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33339441
GET https://conductscience.org/api/papers/v1/33339441/references?page=2